Effect of colchicine on cyclosporine nephrotoxicity, reduction of TGF-beta overexpression, apoptosis, and oxidative damage: An experimental animal study

Transplantation Proceedings

Volumn 36, Issue 5, 2004, Pages 1372-1376

  Disel, U ^a   Paydas, S ^a   Dogan, A ^a   Gulfiliz, G ^a   Yavuz, S ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

COLCHICINE; CREATININE; CYCLOSPORIN; MALONALDEHYDE; OLIVE OIL; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTERIOLE; ARTICLE; CELL COUNT; CELL DEATH; CELL INFILTRATION; CELL VACUOLE; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; CREATININE CLEARANCE; DOSE RESPONSE; DRUG EFFECT; FIBROSING ALVEOLITIS; GENE OVEREXPRESSION; HOST; HYALINE DEGENERATION; IMMUNOHISTOCHEMISTRY; KIDNEY FUNCTION; KIDNEY TUBULE; MALE; MONONUCLEAR CELL; NEPHROTOXICITY; NICK END LABELING; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SERUM; STAINING; STATISTICAL SIGNIFICANCE; TISSUE DISTRIBUTION;

ANIMALS; APOPTOSIS; ARTERIOLES; COLCHICINE; CREATININE; CYCLOSPORINE; KIDNEY; MALE; MALONDIALDEHYDE; MODELS, ANIMAL; OXIDATION-REDUCTION; RATS; RATS, WISTAR; RENAL CIRCULATION; TRANSFORMING GROWTH FACTOR BETA;

EID: 3142646897     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.05.078     Document Type: Article

References (23)

1. Johnson D.W., Saunders H.J., Johnson F.J., et al. Fibrogenic effects of cyclosporin A on the tubulointerstitium role of cytokines and growth Factors. Experimental Nephrology. 5-6:1997;470
2. Wolf G., Thasis F., Stahl R.A. Cyclosporine stimulates expression of transforming growth factor-β in renal cells. Transplantation. 60:1995;237
3. Mason J., Schweinitzer M.E., Dupont M., et al. Cyclosporine and renin angiotensin system. Kidney Int. 39:(Suppl 2):1991;28
4. Thomas S.E., Andoh T.F., Pichler R.H., et al. Accelerated apoptosis characterize cyclosporine-associated interstitial fibrosis. Kidney Int. 53:1998;897
5. Chung K.Y., Kang D.S. Regulation of type 1 collagen and interstitial collagenase mRNA expression in human dermal fibroblasts by colchicine and D-penicillamine. Yonsei Med J. 40:1999;490
6. El-Sakka A.I., Bakircioglu M.E., Bhatnagar R.S., et al. The effects of colchicine on a Peyronie's-like condition in an animal model. J Urol. 161:1999;1980
7. Li C., Yang C Woo, Ahn H.J., et al. Colchicine decreases apoptotic cell death in chronic cyclosporine nephrotoxicity. J Lab Clin Med. 139:2002;364
8. Gutteridge J.M., Halliwell B. The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem Sci. 15:1990;129
9. 1 and matrix proteins in experimental chronic cyclosporine nephropathy. Am J Kidney Dis. 30:1997;71
10. Das D., Pemberton P.W., Burrows P.C., et al. Antioxidant properties of colchicine in acute carbon tetrachloride-induced rat liver injury and its role in the resolution of established cirrhosis. Biochim Biophys Acta. 1502:2000;351
11. Pankewycz O.G., Miao L., Isaacs R., et al. Increased renal tubular expression of transforming growth factor beta in human allografts correlates cyclosporine toxicity. Kidney Int. 50:1996;1634
12. Wolf G., Thasis F., Stahl R.A. Cyclosporine stimulates expression of transforming growth factor-β in renal cells. Transplantation. 60:1995;237
13. 1 and renal injury following subtotal nephrectomy in the rat Role of the renin-angiotensin system. Kidney Int. 51:1997;1553
14. Johnson D.W., Saunders H.J., Johnson F.J., et al. Cyclosporin exerts a direct fibrogenic effect on human tubulointerstitial cells roles of insulin-like growth factor 1, transforming growth factor β1, and platelet-derived growth factor. J Pharmacol Exp Thera. 289:1999;535
15. Kashiwagi M., Shinozaki M., Hirakata M., et al. Locally activated renin-angiotensin system associated with Tgf-β1 as a major factor for renal injury induced by chronic inhibition of nitric oxide synthase in rats. J Am Soc Nephrol. 11:2000;616
16. 1 of progressive kidney fibrosis. Kidney Int. 45:1994;916
17. Sobh M., Sabry A., Moustafa F., et al. Effect of colchicine on chronic cyclosporin nephrotoxicity in Sprague-Dawley rats. Nephron. 79:1998;452
18. Nahioah M., Kumar V.K., Shifow A.A., et al. Lacidipine protects against cyclosporine-induced nephrotoxicity in rats. Nephron. 81:1999;60
19. Kumar K.V., Naidu M.U., Shifow A.A., et al. Melatonin an antioxidant protects against cyclosporine induced nephrotoxicity. Transplantation. 67:1999;1065
20. Saikumar P., Dong Z., Mikhailov V., et al. Apoptosis definition, mechanism, and relevance to disease. Am J Med. 107:1999;489
21. Thomas S.E., Antoh T.F., Pichler R.H., et al. Accelerated apoptosis characterizes cyclosporine-associated intersititial fibrosis. Kidney Int. 53:1998;897
22. Shibab F.S., Andoh T., Tanner A.M., et al. Expression of apoptosis regulatory genes in chronic cyclosporine nephrotoxicity favors apoptosis. Kidney Int. 56:1999;2147
23. Hammerman M.R. Growth factors and apoptosis in acute renal injury. Current Opinion in Nephrology and Hypertension. 7:1998;419